PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Breaking down cancer's defense mechanisms

2013-12-20
(Press-News.org) Contact information: Sarah Collins
sarah.collins@admin.cam.ac.uk
44-012-237-60335
University of Cambridge
Breaking down cancer's defense mechanisms

A possible new method for treating pancreatic cancer which enables the body's immune system to attack and kill cancer cells has been developed by researchers.

The method uses a drug which breaks down the protective barrier surrounding pancreatic cancer tumours, enabling cancer-attacking T cells to get through. The drug is used in combination with an antibody that blocks a second target, which improves the activity of these T cells.

Initial tests of the combined treatment, carried out by researchers at the University's Cancer Research UK Cambridge Institute, resulted in almost complete elimination of cancer cells in one week. The findings, reported in the journal PNAS, mark the first time this has been achieved in any pancreatic cancer model. In addition to pancreatic cancer, the approach could potentially be used in other types of solid tumour cancers.

Pancreatic cancer is the fifth most common cause of cancer-related death in the UK and the eighth most common worldwide. It affects men and women equally, and is more common in people over the age of 60.

As it has very few symptoms in its early stages, pancreatic cancer is usually only diagnosed once it is relatively advanced, and prognosis is poor: for all stages combined, the one and five-year survival rates are 25% and 26% respectively. Tumour removal is the most effective treatment, but it is suitable for just one in five patients.

Immunotherapy – stimulating the immune system to attack cancer cells – is a promising therapy for several types of solid tumours, but patients with pancreatic cancer have not responded to this approach, perhaps because the human form of the cancer, as in animal models, also creates a protective barrier around itself.

The research, led by Professor Douglas Fearon, determined that this barrier is created by a chemokine protein, CXCL12, which is produced by a specialised kind of connective tissue cell, called a carcinoma-associated fibroblast, or CAF. The CXCL12 protein then coats the cancer cells where it acts as a biological shield that keeps T cells away. The effect of the shield was overcome by using a drug that specifically prevents the T cells from interacting with CXCL12.

"We observed that T cells were absent from the part of the tumour containing the cancer cells that were coated with chemokine, and the principal source of the chemokine was the CAFs," said Professor Fearon. "Interestingly, depleting the CAFs from the pancreatic cancer had a similar effect of allowing immune control of the tumour growth."

The drug used by the researchers was AMD3100, also known as Plerixafor, which blocks CXCR4, the receptor on the T cells for CXCL12, enabling T cells to reach and kill the cancer cells in pancreatic cancer models. When used in combination with anti-PD-L1, an immunotherapeutic antibody which enhances the activation of the T cells, the number of cancer cells and the volume of the tumour were greatly diminished. Following combined treatment for one week, the residual tumour was composed only of premalignant cells and inflammatory cells.

"By enabling the body to use its own defences to attack cancer, this approach has the potential to greatly improve treatment of solid tumours," said Professor Fearon.



INFORMATION:

The research was supported by GlaxoSmithKline, the Medical Research Council, Addenbrooke's Charitable Trust, the Ludwig Institute for Cancer Research, the Anthony Cerami and Anne Dunne Foundation for World Health, and Cancer Research UK.



ELSE PRESS RELEASES FROM THIS DATE:

A gluttonous plant reveals how its cellular power plant devours foreign DNA

2013-12-20
A gluttonous plant reveals how its cellular power plant devours foreign DNA Amborella trichopoda, a sprawling shrub that grows on just a single island in the remote South Pacific, is the only plant in its family and genus. It is also one of the oldest flowering ...

Charge order competes with superconductivity

2013-12-20
Charge order competes with superconductivity Today in Science express: Charge carriers in cuprate high-Tc superconductors form nanostripes that suppress superconductivity, as shown by guest researchers from Princeton ...

Elucidating biological cells' transport mechanisms

2013-12-20
Elucidating biological cells' transport mechanisms A new study focuses on the motion of motor proteins in living cells, applying a physicist's tool called non-equilibrium statistical mechanics Motion fascinates physicists. It becomes even more intriguing when ...

How the cells remove copper

2013-12-20
How the cells remove copper We are fundamentally dependent on the presence of copper in the cells of the body. Copper is actually part of the body's energy conversion and protective mechanisms against oxygen radicals, as well as part of the immune system, and it also has great ...

New research provides insight into epilepsy

2013-12-20
New research provides insight into epilepsy Jørgen Kjems and Morten Trillingsgaard Venø, Department of Molecular Biology and Genetics and the Interdisciplinary Nanoscience Centre (iNANO), contribute to an article on microRNA-128 just published in Science. ...

EARTH Magazine: Navigating the risks of hazard research

2013-12-20
EARTH Magazine: Navigating the risks of hazard research Alexandria, VA – When individuals die in a natural disaster or property damage is costly, can anyone be blamed? After the 2012 conviction of six Italian geoscientists on manslaughter charges related ...

Half of National Lottery in Spain sold at Christmas

2013-12-20
Half of National Lottery in Spain sold at Christmas Sales of the National Lottery have fallen for the last five years, which shows that even the most traditional games have been affected by the economic crisis. In 2012, it collected 5.0163 billion euros, down 4.8% from 2011 ...

Neurobiology: The logistics of learning

2013-12-20
Neurobiology: The logistics of learning Learning requires constant reconfiguration of the connections between nerve cells. Two new studies now yield new insights into the molecular mechanisms that underlie the learning process. Learning and memory ...

Increasing personal savings, the 'Groundhog Day' way

2013-12-20
Increasing personal savings, the 'Groundhog Day' way How a cyclical concept of time can boost your bank account Thinking about time as a cycle of recurring experiences — a reality Bill Murray's character knows all too well in the movie ...

Early detection of blinding eye disease could be as easy as scanning a barcode

2013-12-20
Early detection of blinding eye disease could be as easy as scanning a barcode New hand-held optical device to catch early signs of retinal disease

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Breaking down cancer's defense mechanisms